Nimoli Pharmaceuticals (P) Ltd. - Company Profile

It is a pharma private limited company based in New Delhi, Delhi, India, established in 1998.
1998 New Delhi, Delhi, India Active
Last Updated:
Access Report
About Nimoli Pharmaceuticals (P) Ltd.

Nimoli Pharmaceuticals (P) Ltd., a active private limited company, was established on 04 August 1998 in New Delhi, Delhi, India. Engaging in pharmaceutical retailers & distributors within the manufacturing sector, it holds CIN: U24232DL1998PTC361925. Registered under ROC Roc Delhi Ii. it is unlisted. It has an authorized capital of ₹4.00 M and a paid-up capital of ₹2.60 M.

Formerly known as Nimoli Pharmaceuticals Private Limited. It upholds a compliant status. Employing 22 professional, Its leadership includes Vimla Sharma (Director), Vinod Kumar Sharma (Director), Sudesh Bansal (Director). Past directors included Kulbhushan Bansal. It holds no open charges and ₹1.11 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Unit 301, Blk. Pkt. E Lsc Vikas Puri, Near Dusshera Ground, New Delhi, Delhi, 110018.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24232DL1998PTC361925

  • Registration Number

    361925

  • Incorporation Date

    04 August 1998

  • Authorized Capital

    ₹4.00 M

  • Paid-Up Capital

    ₹2.60 M

  • ROC Code

    Roc Delhi Ii

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 4.00 M
  • Paid Up Capital ₹ 2.60 M
  • Company Age 27 Year, 7 Months
  • Last Filing with ROC 31 Mar 2025
  • Satisfied Charges ₹ 1.11 Cr
  • Revenue Growth **** 12.34%
  • Profit Growth **** 25.38%
  • Ebitda **** -33.75%
  • Net Worth 7.44%
  • Total Assets -1.47%
Company report

Nimoli Pharmaceuticals (P) Ltd.

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Nimoli Pharmaceuticals (P) Ltd. — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Nimoli Pharmaceuticals (P) Ltd.?
Current Directors
Name Designation Appointment Date Status
Vimla Sharma Director 16 Aug 2005 Current
Vinod Kumar Sharma Director 04 Aug 1998 Current
Sudesh Bansal Director 16 Aug 2005 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 04 Oct 2016 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Nimoli Pharmaceuticals (P).

Nimoli Pharmaceuticals (P) Ltd., for the financial year ended 2022, experienced significant growth in revenue, with a 12.34% increase. The company also saw a substantial improvement in profitability, with a 25.38% increase in profit. The company's net worth moved up by a moderate rise of 7.44%.

Nimoli Pharmaceuticals (P) revenue growth over time
Nimoli Pharmaceuticals (P) profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 12.34%
*******
*******
*******
*******
Revenue from Operations
*******
 12.27%
*******
*******
*******
*******
Total Assets
*******
 -1.47%
*******
*******
*******
*******
Profit or Loss
*******
 25.38%
*******
*******
*******
*******
Net Worth
*******
 7.44%
*******
*******
*******
*******
EBITDA
*******
 -33.75%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Nimoli Pharmaceuticals (P)?

In 2020, Nimoli Pharmaceuticals (P) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹0

Satisfied Charges

₹11,050,000.00

Charges Breakdown by Lending Institutions
  • Axis Bank Limited : 0.75 Cr
  • Icici Bank Limited : 0.36 Cr
Latest Charge Details
Date Lender Amount Status
19 Jun 2017 Axis Bank Limited ₹7.50 M Satisfied
13 Jan 2011 Icici Bank Limited ₹3.55 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Nimoli Pharmaceuticals (P)?

Nimoli Pharmaceuticals (P) has a workforce of 22 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Nimoli Pharmaceuticals (P), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nimoli Pharmaceuticals (P)'s trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Nimoli Pharmaceuticals (P)
Recent Activity within the Organization
  • Annual General Meeting

    Nimoli Pharmaceuticals (P) Ltd. last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    The activity Nimoli Pharmaceuticals (P) Ltd. has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi Ii. was completed.

  • Charges

    The activity A charge registered on 19 Jun 2017 via Charge ID 100109326 with Axis Bank Limited was fully satisfied on 13 Aug 2024. was completed.

  • Charges

    A charge with Axis Bank Limited of Rs. 7.50 M registered on 19 Jun 2017 with Charge ID 100109326 was modified on 03 Aug 2018. was recorded as a recent event.

  • Charges

    A charge with Axis Bank Limited amounted to Rs. 7.50 M with Charge ID 100109326 was registered on 19 Jun 2017. was recorded as a recent event.

  • Charges

    A charge registered on 13 Jan 2011 via Charge ID 10266541 with Icici Bank Limited was fully satisfied on 29 May 2017. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Nimoli Pharmaceuticals (P) Ltd.?

The CIN of Nimoli Pharmaceuticals (P) Ltd. is U24232DL1998PTC361925.

Where is Nimoli Pharmaceuticals (P) Ltd. headquartered?

Nimoli Pharmaceuticals (P) Ltd. is headquartered at Unit 301, Blk. Pkt. E Lsc Vikas Puri, Near Dusshera Ground, New Delhi, Delhi, 110018.

When was Nimoli Pharmaceuticals (P) Ltd. incorporated?

Nimoli Pharmaceuticals (P) Ltd. was incorporated on 04 August 1998.

Who are the current directors of Nimoli Pharmaceuticals (P) Ltd.?

The current directors of Nimoli Pharmaceuticals (P) Ltd. are

What is the primary industry of Nimoli Pharmaceuticals (P) Ltd.?

The primary industry of Nimoli Pharmaceuticals (P) Ltd. is Manufacturing.

Is Nimoli Pharmaceuticals (P) Ltd. a listed company?

Nimoli Pharmaceuticals (P) Ltd. is unlisted.

What is the capital structure of Nimoli Pharmaceuticals (P) Ltd.?

The authorized capital of Nimoli Pharmaceuticals (P) Ltd. is ₹4.00 M, and the paid-up capital is ₹2.60 M.

What is the compliance status of Nimoli Pharmaceuticals (P) Ltd.?

The compliance status of Nimoli Pharmaceuticals (P) Ltd. is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available